Annika Bansal – Lifestyle
Author:
Belite Bio, Inc
Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit
April 27, 2026
Belite Bio to Participate in Four Upcoming Investor Conferences
April 23, 2026
Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease
April 21, 2026
Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
March 31, 2026
Belite Bio to Participate in the Leerink Global Healthcare Conference
March 5, 2026
Belite Bio Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
March 5, 2026